Lang PD - Search Results

1

Bezafibrate: lack of effect on creatinine excretion and muscular proteins.

Mertz DP, Lang PD, Vollmar J. Mertz DP, et al. Among authors: lang pd. Res Exp Med (Berl). 1982;180(1):95-8. doi: 10.1007/BF01852236. Res Exp Med (Berl). 1982. PMID: 7079594

2

Diurnal lipid and lipoprotein profiles in hypertriglyceridemic patients with bezafibrate and clofibrate.

Oster P, Lang PD, Vollmar J, Schlierf G. Oster P, et al. Among authors: lang pd. Res Exp Med (Berl). 1986;186(6):435-41. doi: 10.1007/BF01852196. Res Exp Med (Berl). 1986. PMID: 3823619 Clinical Trial.

3

Bezafibrate does not influence the QT interval in man.

Olsson AG, Ekelund LG, Lang PD, Vollmar J. Olsson AG, et al. Among authors: lang pd. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):341-2. J Cardiovasc Pharmacol. 1983. PMID: 6188913 No abstract available.

4

[Bezafibrate and delayed action etofibrate in hyperlipidemia].

Lang PD, Vollmar J. Lang PD, et al. Dtsch Med Wochenschr. 1983 Feb 25;108(8):302-5. doi: 10.1055/s-2008-1069545. Dtsch Med Wochenschr. 1983. PMID: 6825604 German. No abstract available.

5

[Lipid-lowering effect of bezafibrate in patients with diabetes mellitus and hyperlipidaemia (author's transl)].

Wahl P, Hasslacher C, Lang PD, Vollmar J. Wahl P, et al. Among authors: lang pd. Dtsch Med Wochenschr. 1978 Aug 4;103(31):1233-7. doi: 10.1055/s-0028-1129237. Dtsch Med Wochenschr. 1978. PMID: 668570 German.

6

Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia.

Olsson AG, Lang PD, Vollmar J. Olsson AG, et al. Among authors: lang pd. Atherosclerosis. 1985 May;55(2):195-203. doi: 10.1016/0021-9150(85)90098-x. Atherosclerosis. 1985. PMID: 4004990

7

Fatty acid composition of adipose tissue, blood, lipids, and glucose tolerance in patients with different degrees of angiographically documented coronary arteriosclerosis.

Lang PD, Degott M, Heuck CC, Opherk D, Vollmar J. Lang PD, et al. Res Exp Med (Berl). 1982;180(2):161-8. doi: 10.1007/BF01851055. Res Exp Med (Berl). 1982. PMID: 6808619

8

Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.

Oster P, Schlierf G, Lang PD, Mordasini R, Vollmar J. Oster P, et al. Among authors: lang pd. Pharmatherapeutica. 1985;4(5):267-77. Pharmatherapeutica. 1985. PMID: 4070320 Clinical Trial.

9

[Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].

Koschinsky T, Lenhard P, Gries FA, Vogelberg KH, Wolfram G, Lang PD, Vollmar J. Koschinsky T, et al. Among authors: lang pd. Med Klin. 1977 Sep 23;72(38):1537-43. Med Klin. 1977. PMID: 904549 Clinical Trial. German.

10

[Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus].

Lang PD, Wahl P, Hassalacher Ch, Vollmar J. Lang PD, et al. Arzneimittelforschung. 1975 Jan;25(1):117-20. Arzneimittelforschung. 1975. PMID: 807221 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters